SaaS Metrics
NorthStrive Biosciences Announces U.S. Arrival of EL-32 Working Cell Bank and Initiation of Manufacturing Optimization for Dual Myostatin Assets Targeting Muscle Preservation with GLP-1 Therapies in Collaboration with Modulant Biosciences
Keyword: Process Development
NEWPORT BEACH, Calif., April 13, 2026 (GLOBE NEWSWIRE) -- NorthStrive Biosciences Inc. (NorthStrive Biosciences), a wholly owned subsidiary of PMGC Holdings Inc. (PMGC or the Company) (NASDAQ: ELAB),… [+5189 chars]
Read Full Story ↗
Related Content